(Q39139830)

9 September 2017

Enzalutamide, an androgen receptor signaling inhibitor, induces tumor regression in a mouse model of castration-resistant prostate cancer (English)

1 reference

9 September 2017

1 reference

Javier Guerrero

1

1 reference

9 September 2017

Iván E Alfaro

2

1 reference

9 September 2017

Francisco Gómez

3

1 reference

9 September 2017

Andrew A Protter

4

1 reference

9 September 2017

Sebastián Bernales

5

1 reference

9 September 2017

13 June 2013

1 reference

9 September 2017

1 reference

9 September 2017

73

1 reference

9 September 2017

1291-1305

1 reference

9 September 2017

12

1 reference

Molecular mechanisms of castration-resistant prostate cancer progression

9 September 2017

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22674

Androgen regulation of gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22674

Progression of prostate cancer: multiple pathways to androgen independence

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22674

Mechanisms mediating androgen receptor reactivation after castration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22674

Molecular determinants of resistance to antiandrogen therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22674

Increased androgen receptor transcription: a cause of castration-resistant prostate cancer and a possible therapeutic target.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22674

In vivo amplification of the androgen receptor gene and progression of human prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22674

The development of androgen-independent prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22674

Unusual specificity of the androgen receptor in the human prostate tumor cell line LNCaP: high affinity for progestagenic and estrogenic steroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22674

Switch from antagonist to agonist of the androgen receptor bicalutamide is associated with prostate tumour progression in a new model system

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22674

Antagonist/agonist balance of the nonsteroidal antiandrogen bicalutamide (Casodex) in a new prostate cancer model

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22674

Prolonged treatment with bicalutamide induces androgen receptor overexpression and androgen hypersensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22674

Codon 877 mutation in the androgen receptor gene in advanced prostate cancer: relation to antiandrogen withdrawal syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22674

Androgen receptor mutation (T877A) promotes prostate cancer cell growth and cell survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22674

Anti-androgens and the mutated androgen receptor of LNCaP cells: differential effects on binding affinity, heat-shock protein interaction, and transcription activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22674

Ligand-independent androgen receptor activity is activation function-2-independent and resistant to antiandrogens in androgen refractory prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22674

Structure-activity relationship for thiohydantoin androgen receptor antagonists for castration-resistant prostate cancer (CRPC)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22674

Development of a second-generation antiandrogen for treatment of advanced prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22674

Increased survival with enzalutamide in prostate cancer after chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22674

Analyzing real-time PCR data by the comparative C(T) method

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22674

A homogeneous cell-based assay to measure nuclear translocation using beta-galactosidase enzyme fragment complementation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22674

Androgen-regulated expression of arginase 1, arginase 2 and interleukin-8 in human prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22674

Potent antiandrogen and androgen receptor activities of an Angelica gigas-containing herbal formulation: identification of decursin as a novel and active compound with implications for prevention and treatment of prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22674

Androgen receptor amplification is reflected in the transcriptional responses of Vertebral-Cancer of the Prostate cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22674

Castration resistance in human prostate cancer is conferred by a frequently occurring androgen receptor splice variant

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22674

PANTHER: a library of protein families and subfamilies indexed by function

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22674

Characterization CSMD1 in a large set of primary lung, head and neck, breast and skin cancer tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22674

BRCA1 counteracts progesterone action by ubiquitination leading to progesterone receptor degradation and epigenetic silencing of target promoters

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22674

BRCA1 16 years later: nuclear import and export processes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22674

Serum/glucocorticoid-induced protein kinase-1 facilitates androgen receptor-dependent cell survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22674

Immunohistochemical analysis of the IL-6 family of cytokines and their receptors in benign, hyperplasic, and malignant human prostate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22674

Interleukin-6 and oncostatin M stimulation of proliferation of prostate cancer 22Rv1 cells through the signaling pathways of p38 mitogen-activated protein kinase and phosphatidylinositol 3-kinase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22674

Steroid up-regulation of FKBP51 and its role in hormone signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22674

Increased expression of androgen receptor sensitizes prostate cancer cells to low levels of androgens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22674

Antiandrogen bicalutamide promotes tumor growth in a novel androgen-dependent prostate cancer xenograft model derived from a bicalutamide-treated patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22674

Structural basis for antagonism and resistance of bicalutamide in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22674

The FXXLF motif mediates androgen receptor-specific interactions with coregulators

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22674

The structural basis of androgen receptor activation: intramolecular and intermolecular amino-carboxy interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22674

Compartmentalization of androgen receptor protein-protein interactions in living cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22674

Characterization of nuclear import of the domain-specific androgen receptor in association with the importin alpha/beta and Ran-guanosine 5'-triphosphate systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22674

Characterization of androgen receptor structure and nucleocytoplasmic shuttling of the rice field eel.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22674

Identification and characterization of a ligand-regulated nuclear export signal in androgen receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22674

Structural basis for the nuclear import of the human androgen receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22674

Evidence for an anti-parallel orientation of the ligand-activated human androgen receptor dimer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22674

Activity of androgen receptor antagonist bicalutamide in prostate cancer cells is independent of NCoR and SMRT corepressors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22674

Bicalutamide functions as an androgen receptor antagonist by assembly of a transcriptionally inactive receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22674

The androgen receptor recruits nuclear receptor CoRepressor (N-CoR) in the presence of mifepristone via its N and C termini revealing a novel molecular mechanism for androgen receptor antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22674

The androgen receptor T877A mutant recruits LXXLL and FXXLF peptides differently than wild-type androgen receptor in a time-resolved fluorescence resonance energy transfer assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22674

Recruitment of beta-catenin by wild-type or mutant androgen receptors correlates with ligand-stimulated growth of prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22674

Mechanisms of androgen receptor activation in advanced prostate cancer: differential co-activator recruitment and gene expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22674

Wild-type but not mutant androgen receptor inhibits expression of the hTERT telomerase subunit: a novel role of AR mutation for prostate cancer development

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22674

Antiandrogen-induced cell death in LNCaP human prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22674

FoxA1 specifies unique androgen and glucocorticoid receptor binding events in prostate cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22674

21 January 2018

Identifiers

DOI

10.1002/PROS.22674

1 reference

9 September 2017

1 reference